These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29965856)
1. The diagnostic work-up of cancer-associated myositis. Selva-O'Callaghan A; Martinez-Gómez X; Trallero-Araguás E; Pinal-Fernández I Curr Opin Rheumatol; 2018 Nov; 30(6):630-636. PubMed ID: 29965856 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346 [TBL] [Abstract][Full Text] [Related]
3. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751 [TBL] [Abstract][Full Text] [Related]
10. [Autoantibody profile in myositis]. Allenbach Y; Benveniste O Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952 [TBL] [Abstract][Full Text] [Related]
11. Anti-TIF1γ antibody and the expression of TIF1γ in idiopathic inflammatory myopathies. Kim Y; Song KS; Sohn EH; Kang SW; Yoo IS; Shim SC; Yoo SJ; Kim J Int J Rheum Dis; 2019 Feb; 22(2):314-320. PubMed ID: 30398003 [TBL] [Abstract][Full Text] [Related]
12. New insights in myositis-specific autoantibodies. Ghirardello A; Doria A Curr Opin Rheumatol; 2018 Nov; 30(6):614-622. PubMed ID: 30234722 [TBL] [Abstract][Full Text] [Related]
13. [Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody]. Szankai Z; Nagy-Vincze M; Bodoki L; Jakab A; Betteridge Z; Dankó K Orv Hetil; 2014 Sep; 155(36):1437-44. PubMed ID: 25176518 [TBL] [Abstract][Full Text] [Related]
14. Malignancy and myositis: novel autoantibodies and new insights. Selva-O'Callaghan A; Trallero-Araguás E; Grau-Junyent JM; Labrador-Horrillo M Curr Opin Rheumatol; 2010 Nov; 22(6):627-32. PubMed ID: 20827204 [TBL] [Abstract][Full Text] [Related]
15. [A case of anti-nuclear matrix protein 2 antibody positive myopathy associated with lung cancer]. Ohta S; Unoda K; Nakajima H; Ikeda S; Hamaguchi Y; Kimura F Rinsho Shinkeigaku; 2016 Aug; 56(8):573-6. PubMed ID: 27477574 [TBL] [Abstract][Full Text] [Related]
16. Idiopathic inflammatory muscle disease: clinical aspects. Rider LG; Miller FW Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):37-54. PubMed ID: 10882213 [TBL] [Abstract][Full Text] [Related]